SecBot SecBot
Institutional Cluster

TMDX

TransMedics Group, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed5mo ago
Institutional cluster: 25 buyers, 11 sellers (bullish)
Actionable Insight ▲ Bullish

The divergence between active asset-manager accumulation and quant-fund exit is a high-conviction structural signal: active managers are betting on fundamental execution of the OCS commercial rollout, while quants are cutting risk regardless of thesis. Traders should monitor the upcoming quarterly earnings for evidence of OCS case-volume acceleration to validate the activist/active thesis before initiating a long. A break above recent technical resistance on heavy volume would confirm the institutional buying trend.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$72.91
T+0 close · Jun 12, 2026 · via day close
Latest settled
+21.07%
T+60 · $88.27
Vs SPY
+17.80%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 12 $72.91entry
  2. T+1 · 5mo ago +3.52%α +1.76% · $75.48
  3. T+5 · 5mo ago +8.06%α +7.39% · $78.79
  4. T+20 · 4mo ago −2.30%α −4.08% · $71.23
  5. T+60 · 2mo ago +21.07%α +17.80% · $88.27

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

TransMedics attracted heavy net institutional accumulation in Q3 2024, with 25 buyers adding $121.7M in new exposure against 11 sellers reducing $86.5M. Buying was concentrated among major active asset managers (FIL, Franklin Resources, Farallon, Ameriprise) all doubling or more-than-doubling positions, while sellers were primarily quant funds exiting entirely (Citadel, D.E. Shaw, Bridgewater). The active-buyer versus quant-seller split suggests fundamental conviction on the OCS platform thesis clashing with systematic risk-off positioning in high-growth medtech.

Key Financial Metrics

Direction
accumulating
Buy Value
$247.8M
Sell Value
$0.00
Net Flow
$35.2M

Institutional Positions

Net institutional flow: $35.2M

▲ Buyers (25)

InstitutionActionChangePosition ValueValue Δ
Fil (Fidelity)DOUBLED+107.4%$122.7M$65.9M
Franklin ResourcesDOUBLED+124%$36.3M$18.1M
Norges BankADD+32.7%$56.2M$15.6M
Ameriprise FinancialDOUBLED+112.3%$19.2M$10.6M
Farallon Capital ManagementDOUBLED+2100%$6.9M$6.6M

▼ Sellers (11)

InstitutionActionChangePrev ValueValue Δ
D.E. ShawEXIT-100%$31.7M-$31.7M
Voloridge Investment ManagementTRIM-28.4%$66.3M-$16.8M
Canada Pension Plan Investment BoardTRIM-74.6%$16.1M-$11.8M
CitadelEXIT-100%$11.8M-$11.8M
Prudential FinancialNEAR_EXIT-95.2%$9.6M-$9.1M

Key Facts

  • Net aggregate institutional inflow of $35.2M (25 buyers at +$121.7M vs 11 sellers at -$86.5M)
  • FIL (Fidelity) more than doubled its stake to $122.7M, the largest single buyer at +$65.9M
  • Franklin Resources doubled to $36.3M (+$18.1M) and Ameriprise doubled to $19.2M (+$10.6M)
  • D.E. Shaw fully exited a $31.7M position; Citadel fully exited an $11.8M position
  • Farallon Capital Management boosted a near-mid size position by 21x to $6.9M
  • Selling was dominated by quant/multi-manager funds (D.E. Shaw, Citadel, Bridgewater, Voloridge), pattern consistent with systematic risk reduction, not fundamental bearishness

Financial Impact

Net institutional inflow of approximately $35.2M, with $147.8M of concentrated active-manager additions offsetting $86.5M of quant/MM fund reductions

institutional_ownership_shiftshare_float_demand

Risk Factors

  • Active-manager accumulation occurred in Q3 2024; 13F data filed with a 45-day lag may not reflect current positioning
  • D.E. Shaw and Citadel full exits indicate sophisticated multi-manager funds see risk factors the active buyers may be underestimating
  • Potential post-de-SPAC dilution overhang or pending share issuance
  • Sector rotation out of high-growth medtech could overwhelm active-manager demand

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
74% bullish (19 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-TMDX-2024-Q3

Track record

9 reports on TMDX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $90.95 settles Nov 17
  2. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $88.24 to $91.38 ▲ +3.56% +0.96% vs SPY
  3. Nov 5, 202611d ago Press Release Bullish 6/10 No price data
  4. Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Viewing Entry $72.91 to $78.79 ▲ +8.06% +7.39% vs SPY
  5. Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 ▼ −0.50% −0.94% vs SPY
  6. Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 ▲ +1.64% −2.86% vs SPY
  7. Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 ▼ −8.32% −7.11% vs SPY
  8. Feb 27, 202637w ago 8-K Neutral 4/10 Entry $145.26 to $129.61 ▼ −10.77% −8.79% vs SPY
  9. Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 ▲ +11.99% +13.09% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 6h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026